BlackRock’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,015,374
| Closed | -$638M | – | 5327 |
|
|
2023
Q4 | $638M | Buy |
2,015,374
+52,457
| +3% | +$16.6M | 0.02% | 811 |
|
|
2023
Q3 | $332M | Buy |
1,962,917
+98,281
| +5% | +$16.6M | 0.01% | 1193 |
|
|
2023
Q2 | $404M | Sell |
1,864,636
-605,163
| -25% | -$131M | 0.01% | 1088 |
|
|
2023
Q1 | $449M | Buy |
2,469,799
+66,068
| +3% | +$12M | 0.01% | 977 |
|
|
2022
Q4 | $472M | Buy |
2,403,731
+146,037
| +6% | +$28.7M | 0.01% | 919 |
|
|
2022
Q3 | $508M | Buy |
2,257,694
+371,050
| +20% | +$83.5M | 0.02% | 803 |
|
|
2022
Q2 | $239M | Buy |
1,886,644
+260,239
| +16% | +$32.9M | 0.01% | 1386 |
|
|
2022
Q1 | $206M | Sell |
1,626,405
-12,212
| -0.7% | -$1.55M | 0.01% | 1645 |
|
|
2021
Q4 | $215M | Buy |
1,638,617
+55,120
| +3% | +$7.22M | 0.01% | 1683 |
|
|
2021
Q3 | $194M | Buy |
1,583,497
+3,780
| +0.2% | +$462K | 0.01% | 1726 |
|
|
2021
Q2 | $180M | Buy |
1,579,717
+179,462
| +13% | +$20.5M | 0.01% | 1832 |
|
|
2021
Q1 | $168M | Buy |
1,400,255
+26,543
| +2% | +$3.19M | ﹤0.01% | 1833 |
|
|
2020
Q4 | $140M | Buy |
1,373,712
+86,154
| +7% | +$8.75M | ﹤0.01% | 1844 |
|
|
2020
Q3 | $99.6M | Buy |
1,287,558
+27,853
| +2% | +$2.15M | ﹤0.01% | 1863 |
|
|
2020
Q2 | $140M | Buy |
1,259,705
+319,129
| +34% | +$35.6M | 0.01% | 1598 |
|
|
2020
Q1 | $67.7M | Buy |
940,576
+320,218
| +52% | +$23.1M | ﹤0.01% | 1879 |
|
|
2019
Q4 | $46.7M | Buy |
620,358
+346,576
| +127% | +$26.1M | ﹤0.01% | 2385 |
|
|
2019
Q3 | $4.47M | Buy |
+273,782
| New | +$4.47M | ﹤0.01% | 3476 |
|